Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01003574 · ClinicalTrials.gov registry record · NA
Evaluation of Cardiovascular Health Outcomes Among Survivors
A NA study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- NA
- Development phase
- 509
- Enrollment target
NCT01003574: Completed NA study, sponsored by St. Jude Children's Research Hospital.
NCT01003574 is a NA study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 509 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01003574, a NA study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 509 participants
- Enrollment target
Study Summary
This study will test a 2-tiered tailored intervention and evaluation of cardiovascular health outcomes among survivors designed to inform childhood cancer survivors about their individual cardiac risk and follow-up recommendations and to provide motivational support for cardiovascular (CV) screening. This study will test if the addition of telephone motivational interviewing, tailored to behavioral constructs, is superior to the current standard of care in increasing survivors' CV screening.
Interventions
- BEHAVIORAL lifestyle modification and telephone counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 509 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-07 |
| Phase | NA |
What the finished NCT01003574 record still lists
NCT01003574 is an interventional study that assigns participants to a tested intervention. The registered 509 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 1 intervention - of which lifestyle modification and telephone counseling is the first listed.
NCT01003574 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01003574 about?
NCT01003574 is a clinical study titled "Evaluation of Cardiovascular Health Outcomes Among Survivors". This study will test a 2-tiered tailored intervention and evaluation of cardiovascular health outcomes among survivors designed to inform childhood cancer survivors about their individual cardiac risk and follow-up recommendations and to provide motivational support for cardiovascular (CV) screening...
What is the current status of trial NCT01003574?
This trial is currently completed. It is a NA study. The enrollment target is 509 participants. The study started on 2010-03. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01003574?
The interventions under investigation include: lifestyle modification and telephone counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01003574?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01003574's enrollment target sits among peer trials
509 192nd of 2000 higher than 1,809 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03922542 · 510 participants · Phase 2
Comparison of Standard vs. Accelerated Corneal Crosslinking
- NCT04634552 · 510 participants · Phase 2
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- NCT05164744 · 510 participants
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
- NCT05451004 · 510 participants · Phase 3
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia